In the MENA region, the lack of standardized guidelines for Duchenne muscular dystrophy (DMD) leads to delays in diagnosis and treatment.

​

Our goal is to develop AI-powered software that will analyze low-cost MRI images of muscle tissue for the purpose of early detection and comprehensive assessment of disease management.